Research & Development
Partnering
GlycoMar's success is dependent on collaboration with commercial and academic partners to develop, produce and market products.
GlycoMar has a Licensing and Collaboration agreement with Verona Pharma plc. for the development of Novel Anti-inflammatory Polysaccharides (NAIPs) for treatment of respiratory inflammation. GlycoMar also has a Licensing and Collaboration agreement with Scanbio AS, of Norway, for development of a nutritional supplement derived from fish by-product.
In addition to these key collaboration GlycMar is continuing to seek new partners interested in developing intellectual property (IP) based on marine natural products, or provide technical and commercial capabilities not available in house. We will consider joint ventures where IP is shared, or licensed.
We are particularly interested in pharmaceutical, nutraceutical or cosmeceutical organisations as potential licensees.
If you are interested in licensing GlycoMar’s technology or if you have technology that may be of interest to GlycoMar please contact us.
Collaboration
GlycoMar has established key collaborations with academic partners including:
Dr Dusan Uhrin, Reader in NMR Spectroscopy at the University of Edinburgh School of Chemistry - collaboration around characterisation of marine glycosaminoglycan structures using NMR spectroscopy. GlycoMar sponsors a SPIRIT Phd Studentship in Dr Uhrin's lab.
Prof. Marcel Jaspars, Professor of Organic Chemistry at Univeristy of Aberdeen Marine Biodiscovery Centre - marine natural products drug disovery collaboration.
Scottish Association for Marine Science - multiple collaborations including Genomia funded Holopharm project with Dr Maeve Kelly's group to characterise potential new drugs isolated from sea cucmber
Dr. Cathy Merry, Lecturer in Biomedical Materials atthe University of Manchester - ESPRC KTA funded grant to study 3D scaffolds for stem cell cuture from marine biomaterials.
Prof Paul De Sousa, Centre for Regenerative Medicine, University of Edinburgh - EU FP7 funded BEST Stem Cells project.
BEADS project - Bioengineered microencapsulation of active agents delivered to shellfish - EU FP7 funded project.
GlycoMar is working with MicroA of Norway for the pilot-scale production of one of GlycoMar’s biologically active polysaccharides from a marine microalga using MicroA’s patented photobioreactor (PBR) technology.
GlycoMar is part of the SUBMARINER blue biotech network.
For more information on the biotechnology industry visit biotechnologycompanies.net.